viernes, 18 de agosto de 2023

FDA Denies Vanda’s Citizen Petitions Regarding the Need for Braille Labeling for Tasimelteon Generics By Mark A. Tobolowsky —

https://www.thefdalawblog.com/2023/08/fda-denies-vandas-citizen-petitions-regarding-the-need-for-braille-labeling-for-tasimelteon-generics/?utm_source=rss&utm_medium=rss&utm_campaign=fda-denies-vandas-citizen-petitions-regarding-the-need-for-braille-labeling-for-tasimelteon-generics

No hay comentarios: